Anti-Human CD4 Recombinant Antibody(Priliximab)

Product Information

Catalog Number	YR1098
Product Name	Anti-Human CD4 Recombinant Antibody(Priliximab)
Molecular Name	Priliximab
Alias	Anti-CD4 Recombinant Antibody, Research Grade Priliximab
Target	CD4[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licensing. The patent belongs to the biotechnology company Centocor.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price